EdgarLookup

Hasnain Faheem

Insider transactions at 6 companies

This page shows all SEC Form 4 filings attributed to Hasnain Faheem. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

BIIB NUVB KURA FBRX IMUX GOSS
Company Title Type Shares Price Value Date
KURA Sale 10,000 $10.98 $109,800 Dec 9, 2025
GOSS President & CEO Award / Grant 437,500 Oct 1, 2025
KURA Sale 22,682 $8.00 $181,456 Mar 21, 2025
GOSS President & CEO Purchase 372,000 $0.67 $249,240 Jun 21, 2024
GOSS President & CEO Sale 23,172 $1.16 $26,880 Mar 27, 2024
0001576263 Disposition 8,717 Jan 23, 2024
0001576263 Award / Grant 9,702 $58.75 $569,993 Dec 29, 2023
0001576263 Purchase 10,791 $27.80 $299,990 Aug 11, 2023
GOSS President & CEO Award / Grant 540,176 $1.82 $983,120 Jul 24, 2023
GOSS President & CEO Purchase 440,500 $1.14 $502,170 Mar 21, 2023
0001576263 Award / Grant 6,333 Jan 20, 2023
GOSS President & CEO Purchase 138,696 $7.21 $999,998 Jul 15, 2022
GOSS President & CEO Sale 19,035 $8.92 $169,792 Mar 23, 2022
0001576263 Award / Grant 3,619 Jan 14, 2022
GOSS President & CEO Award / Grant 162,500 Feb 25, 2021
NUVB Award / Grant 30,000 $10.00 $300,000 Feb 10, 2021
0001576263 Award / Grant 2,098 Jan 15, 2021
GOSS Purchase 96,520 $10.36 $999,947 Oct 14, 2020
0001576263 Award / Grant 3,000 Jan 3, 2020
GOSS Purchase 10,000 $16.80 $168,000 Sep 27, 2019
FBRX Purchase 38,860 $4.59 $178,367 May 30, 2019
GOSS Executive Chairman C 58,599 Feb 12, 2019
IMUX Sale 59,200 $0.44 $26,048 Sep 13, 2018
IMUX Purchase 59,200 $4.19 $248,048 Sep 14, 2017
FBRX Other 102,857 $10.00 $1,028,570 Apr 19, 2017
IMUX Purchase 118,243 $5.92 $699,999 Aug 12, 2016
0001463729 President & CEO U 384,409 Aug 27, 2015
0001463729 President & CEO Award / Grant 32,500 Apr 1, 2015
0001463729 President & CEO Sale 63,205 $108.99 $6,888,713 Nov 10, 2014
0001463729 President, CEO C 47,618 $5.25 $249,995 May 14, 2013
0001339455 Disposition 27,974 Mar 6, 2013
0001339455 Award / Grant 7,230 Dec 31, 2012
0001339455 Award / Grant 32,586 Sep 30, 2012
0001339455 Award / Grant 45,789 Jul 2, 2012
0001339455 Award / Grant 59,423 Apr 2, 2012
0001441848 President & CEO Disposition 102,667 $27.00 $2,772,009 Apr 21, 2010
0001441848 President & CEO U 18,463 $27.00 $498,501 Apr 20, 2010
0001441848 President & CEO Tax Withholding 8,937 $17.37 $155,236 Oct 1, 2009
0001441848 President & CEO Award / Grant 27,667 Aug 6, 2009
0001441848 President & CEO Award / Grant 100,000 Jan 23, 2009
0000882104 President & CEO Award / Grant 125,000 Oct 1, 2008
BIIB EVP, Oncology/Rheumatology SBU Option Exercise 20,450 $44.24 $904,708 Jul 9, 2008
BIIB EVP, Oncology/Rheumatology SBU Sale 200 $63.79 $12,758 Apr 8, 2008
BIIB EVP, Oncology/Rheumatology SBU Award / Grant 10,430 Feb 12, 2008
BIIB EVP, Oncology/Rheumatology SBU Tax Withholding 2,017 $60.52 $122,069 Feb 6, 2008
BIIB SVP, Oncology SBU Award / Grant 2,700 Nov 1, 2007
BIIB SVP, Oncology SBU Tax Withholding 3,575 $65.88 $235,521 Oct 4, 2007
BIIB SVP, Oncology SBU Sale 7,446 $49.00 $364,854 May 23, 2007
BIIB SVP, Oncology SBU Sale 7,446 $49.00 $364,854 May 23, 2007
BIIB SVP, Oncology SBU Award / Grant 6,225 Mar 14, 2007